Skip to content

Influence of a weight loss nutritional counselling program on cardiovascular diseease risk factors and the role of adipose tissue hormones on weight maintenance and regain

Influence of a weight loss nutritional counselling program on cardiometabolic profile and the role of adipokines on weight maintenance and regain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-75n6gm
Enrollment
Unknown
Registered
2016-07-22
Start date
2012-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight. Obesity. Metabolic syndrome.

Interventions

52 overweight and obese patients will attend a nutritional counselling program for weight loss (Weight Control Group) in the Nutrition ambulatory at the University Hospital of University of São Paulo
dietary fiber types and sources
and reading and understanding food labels. Biochemical parameters (fasting glucose, insulin, total cholesterol, LDL, HDL, triglycerides, GOT, GPT, leptin, adiponectin), anthropometric parameters (weig
Other
SP6.026

Sponsors

Hospital Universitário da Universidade de São Paulo
Lead Sponsor
Faculdade de Saúde Pública da Universidade de São Paulo
Collaborator

Eligibility

Age
20 Years to 59 Years

Inclusion criteria

Inclusion criteria: Adults (aged 20 to 59 years), both sexes, BMI of at least 25 kg/m2, who have read and signed the written informed consent. The subjects must attend at least 4 of the 5 group meetings.

Exclusion criteria

Exclusion criteria: Participation in other interventional studies; use of weight loss medication; use of illicit drugs; alcoholics; pregnancy or breastfeeding; upper and lower limb amputation; practice of high intensity physical activity; surgical procedures that may influence body weight 3 months prior and/or during the intervention and follow-up period; critical chronic and acute diseases that limit life expectancy in 6 months. Information regarding inclusion and exclusion criteria will be obtained from personal interview and medical records.

Design outcomes

Primary

MeasureTime frame
Weight loss after the intervention, assessed by weight difference between T0 and T1, based on the observation of any variation other than zero over the period.;Cardiometabolic profile improvement after the intervention, assessed by the variations in anthopometric (weight and waist circumference), body composition (bioeletric impedance) and biochemical (blood collection) parameters between T0 and T1, based on the observation of any variation other than zero over the period.;Weight regain 6 months after the end of the intervention, assessed by relative weight regain porcentage, calculated according the folowing equation: (weightT2-weightT1)/(weightT0-weightT1)*100, based on the observation of a variation of at least 10% over the period.;Change in leptin and adiponectin levels (assessed by blood collection and ELISA analysis) after the intervention, based on the observation of any variation other than zero between T0 and T1, and correlation with weight regain 6 months after the end of the intervention.

Secondary

MeasureTime frame
Change in food consumption (assessed by 24-hour recall) and physical activity levels (assessed by Baecke questionnaire) after the intervention and 6 months after the end of the intervention, based on the observation of any change other than zero between T0 and T1 and between T1 and T2 periods.

Countries

Brazil

Contacts

Public ContactNágila Damasceno

Faculdade de Saúde Pública da Universidade de São Paulo

nagila@usp.br+55 (11) 3061 7865

Outcome results

None listed

Source: REBEC (via WHO ICTRP)